Hepatitis C virus infection in Egyptian patients w

Impact of HCV genotype and viral load on the hepatic pathology in Egyptian patients with chronicHCV infection

Changes in chemokines levels in relation to combined interferon and ribavirin therapy in Egyptian patients with chronic hepatitis C

Impact of hepatitis c virological load and bilharzial antibodies on rapid virological response

Evidence of an assocation of diabetes mellitus and chronic hepatitic C virus infection in Egypt

Metformin as an add on therapy in the treatment of hepatitis C virus Egyptian patients

Virological breakthrough in chronic HBV Egyptian patients receiving Lamivudine therapy

Burden of hepatitis C virus in Egypt

Interleukin 28 B genotype as a predictor of response to therapy with pegylated interferon plus ribavirin in HCV infected Egyptian patients

Viral kinetic changes after 4 weeks and its relation to response to Peg. INF therapy in chronic HCV genotype 4 patients